Proactiveinvestors recommends
Additional Information
Market: OTCBB
Sector: Medical
EPIC: POSC
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Positron Corporation
www.positron.com

Positron Corporation offers innovative solutions through the production and distribution of molecular
imaging systems and radiopharmaceutical technologies.

Full Positron Corporation profile here
Pdf

Positron to present at Society of Nuclear Medicine meeting in June

31st May 2011, 2:03 pm by Deborah Sterescu
Positron to present at Society of Nuclear Medicine meeting in June

Positron Corp (OTCBB:POSC), a molecular imaging company specializing in the field of nuclear cardiology, said Tuesday it will be exhibiting at the Society of Nuclear Medicine's (SNM) Annual Meeting, to be held in San Antonio, Texas, from June  4 to 8.

The Indianapolis-based company has developed the PosiRx system, which automates and simplifies the dose preparation and dispensing processes for radiopharmaceutical agents used in molecular imaging.

Radiopharmaceuticals, which feature radioactive isotopes, are used in the field of nuclear medicine as tracers in the diagnosis and treatment of many diseases.

Positron also sells Attrius positron emission tomography (PET) systems that can guide medical and interventional therapy in individual cardiac patients.

"With the increased interest in cardiac PET and the launch of the PosiRx system, our participation at well-respected forums such as SNM is crucial to meeting customers and creating market awareness," said CEO Patrick G. Rooney.

"After attendance at the American College of Cardiologists conference in April and the more recent International Conference of Non-Cardiovascular Imaging in Europe, we have seen a notable increase in interest levels for both the cardiac PET and SPECT pharmaceutical segments of our business.

"The exposure and introductions gained from these industry conferences have yielded opportunities that will advance our future growth.”

Founded in 1954, the Society of Nuclear Medicine, with 16,000 members, including physcians, scientists and technologists, is an international organization that promotes the application of nuclear medicine.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.